6-(butyl(methyl)amino)-3-((1-ethylpiperidin-3-yl)methyl)-2-(2-methoxyphenyl)quinazolin-4(3H)-one

ID: ALA243429

PubChem CID: 23631194

Max Phase: Preclinical

Molecular Formula: C28H38N4O2

Molecular Weight: 462.64

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCN(C)c1ccc2nc(-c3ccccc3OC)n(CC3CCCN(CC)C3)c(=O)c2c1

Standard InChI:  InChI=1S/C28H38N4O2/c1-5-7-16-30(3)22-14-15-25-24(18-22)28(33)32(20-21-11-10-17-31(6-2)19-21)27(29-25)23-12-8-9-13-26(23)34-4/h8-9,12-15,18,21H,5-7,10-11,16-17,19-20H2,1-4H3

Standard InChI Key:  MFHFVHMRADFDJS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    7.7596   -8.8353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4768   -9.2497    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4729   -7.6006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7559   -8.0140    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1888   -8.0126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1849   -8.8357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8947   -9.2487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6087   -8.8399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6085   -8.0137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8982   -7.6044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4726   -6.7756    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0406   -7.6029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0391   -6.7779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7544   -6.3620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7548   -5.5406    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0414   -5.1256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3259   -5.5383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3238   -6.3659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4700   -5.1295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1837   -5.5433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0460   -9.2493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3228   -7.6008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0375   -8.0130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3224   -6.7758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7518   -7.6001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4664   -8.0123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1807   -7.5994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3341   -8.8370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6210   -9.2503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6223  -10.0762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3427  -10.4870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0528  -10.0713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7703  -10.4787    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4818  -10.0611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  8  9  1  0
 15 19  1  0
  3  4  1  0
 19 20  1  0
  9 10  2  0
  1 21  1  0
 10  5  1  0
  9 22  1  0
  1  2  2  0
 22 23  1  0
  3 11  2  0
 22 24  1  0
 23 25  1  0
  4 12  1  0
 25 26  1  0
  5  6  2  0
 26 27  1  0
 13 12  1  0
 21 28  2  0
 13 14  1  0
 28 29  1  0
  1  4  1  0
 29 30  2  0
  6  7  1  0
 30 31  1  0
  2  6  1  0
 31 32  2  0
 32 21  1  0
  7  8  2  0
 32 33  1  0
  5  3  1  0
 33 34  1  0
M  END

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ghrelin receptor (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 462.64Molecular Weight (Monoisotopic): 462.2995AlogP: 5.04#Rotatable Bonds: 9
Polar Surface Area: 50.60Molecular Species: BASEHBA: 6HBD:
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.86CX LogP: 5.01CX LogD: 3.53
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.45Np Likeness Score: -1.34

References

1. Rudolph J, Esler WP, O'connor S, Coish PD, Wickens PL, Brands M, Bierer DE, Bloomquist BT, Bondar G, Chen L, Chuang CY, Claus TH, Fathi Z, Fu W, Khire UR, Kristie JA, Liu XG, Lowe DB, McClure AC, Michels M, Ortiz AA, Ramsden PD, Schoenleber RW, Shelekhin TE, Vakalopoulos A, Tang W, Wang L, Yi L, Gardell SJ, Livingston JN, Sweet LJ, Bullock WH..  (2007)  Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.,  50  (21): [PMID:17887659] [10.1021/jm070071+]

Source